daftar pustaka - eprints.undip.ac.ideprints.undip.ac.id/46164/9/candra_cahyaningtyas_giyanto... ·...

65

DAFTAR PUSTAKA

1. Vitoratos N, Vrachnis N, Iavazzo C, Kyorgiou M. Preeclampsia: molecular

mechanisms, predisposition, and treatment. Journal of Pregnancy[Internet].

2012 [cited 2014 Nov 18]. Available from :

http://dx.doi.org/10.1155/2012/145487.

2. Guerrier G, Oluyide B, Keramarou M, Grais RF. Factors associated with

severe preeclampsiaand eclampsia in Jahun, Nigeria. International Journal of

Women’s Health. 2013; 5; 509-513.

3. Cunningham FG, Levenno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY.

Hipertensi dalam kehamilan. In : Pendit BU, Setia R, editor. Obstetri

williams. 23th ed. Jakarta : Penerbit Buku Kedokteran EGC; 2013 : 740-794.

4. Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone

PJ. Maternal preeclampsia and neonatal outcomes. Journal of Pregnancy

[Internet]. 2011 [cited 2014 Nov 25]. Available from :

http://dx.doi.org/10.1155/2011/214365.

5. Membedah angka kematian ibu : penyebab dan akar masalah tingginya angka

kematian ibu. Konferensi INFID; 2013 November 26-27. Jakarta; 2014.

6. Widiyanto. Kehamilan dengan preeklampsia berat [thesis]. Semarang: Bagian

Obstestri dan Ginekologi Fakultas Kedokteran Universitas Diponegoro; 2005.

7. Manuaba IBG, Manuaba IAC, Manuaba IBGF. Hipertensi dalam kehamilan.

In : Astuti NZ, Purba DI, Handayani S, Damayanti R, editor. Pengantar

kuliah obstetri. Jakarta : Penerbit Buku Kedokteran EGC; 2003.

66

8. DeCherney AH, Nathan L. Hypertensive states of pregnancy. In : Current

obstetric and gynecologic diagnosis and treatment. 9th ed. New York :

McGRAW-HILL Inc; 2003.

9. Canzoneri BJ, Lewis DF, Groome L, Wang Y. Increased neutrophil number

account for leukocytosis in women with preeclampsia. American Journal of

Perinatology. 2011.

10. Gana YY. Hubungan kadar hematokrit dengan derajat preeklampsia.

Surakarta : Fakultas Kedokteran Universitas Sebelas Maret; 2010.

11. Yusrianty D, Lukas E, Tahir M. Kadar serum P38 MAPK, profil darah pada

pasien preeklampsia berat dibandingkan kehamilan normal. JST Kesehatan.

2014; 4(3): 291-298.

12. Adhie RP. Hubungan antara kadar hematokrit dan trombosit maternal

terhadap keluaran perinatal pada eklampsia berat [thesis]. Semarang : Bagian

Obstetri dan Ginekologi Fakultas Kedokteran Universitas Diponegoro; 2004.

13. Kawuryan SL. Pengaruh kadar trombosit, hematokrit, hemoglobin darah dan

protein urin pada ibu preeklampsia/eklampsia terhadap nilai apgar bayi yang

dilahirkan. Jurnal Kedokteran Brawijaya. 2004; 20(2): 78-81.

14. Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstetrics and

Gynecology International[Internet]. 2014 [cited 2014 Nov 17]. Available

from : http://dx.doi.org/10.1155/2014/297397

15. Moura SAMH, Lopes LM, Murthi P, Costa FS. Prevention of preeclampsia.

Journal of Pregnancy[Internet]. 2012 [cited 2014 Nov 17]. Available from :

http://dx.doi.org/10.1155/2012/435090.

67

16. Angsar MD. Hipertensi dalam kehamilan. In : Saifuddin AB, Rachimhadhi T,

Wiknjosastro GH, editor. Ilmu kebidanan sarwono prawirohardjo. Edisi

keempat. Jakarta : Bina Pustaka Sarwono Prawirohadjo; 2011.

17. Birawa AD, Hadisaputro H, Hadijono S. Kadar d-dimer pada ibu hamil

dengan preeklampsia berat dan normotensi di rsup dr. kariadi. Majalah

Obstetri Ginekologi Indonesia. 2009; 33(2): 65-78.

18. Diagnosis and management of preeclampsia and eclampsia. ACOC Practice

Bulletin: Clinical Management Guideline for Obstetrician-Gynecologists.

2002; 33.

19. Vanderlelie J. Placental oxidative stress in preeclampsia[thesis]. Brisbane:

Griffith University; 2005.

20. Powe CE, Levine RJ, Karumanchi A. Preeclampsia, a disease of the maternal

endothelium : the role of antiangiogenic factors and implications for later

cardiovascular disease. American Heart Association Journals. 2014.

21. Indrianto A, Hadisaputro H. Preeklampsia berat di RS Dr. Kariadi periode 1

januari 2004 – 31 desember 2004[thesis]. Semarang: Bagian Obstestri dan

Ginekologi Fakultas Kedokteran Universitas Diponegoro; 2009.

22. Nugroho T. Patologi kebidanan. Yogyakarta: Nuha Medika; 2012: 1-12.

23. Nankali A, Malek-khosravi S, Zangeneh M, Rezaei M, Hemati Z, Kohzadi

M. Maternal complication associated with severe preeclampsia. The Journal

of Obstetrics and Gynecology of India. 2013; 63(2) : 112-115.

68

24. Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. Journal of

Pregnancy[internet]. 2012[cited 2015 Jan 19]. Availabel from:

http://dx.doi.org/10.1155/2012/586578.

25. Sacher RA, McPherson RA. Widmann’s clinical interpretation of laboratory

test. In : Brahm U, Wulandari D, Hartanto H. Tinjauan klinis hasil

pemeriksaan laboratorium. 11th

ed. Jakarta : Penerbit Buku Kedokteran EGC;

2004 : 21-66.

26. Tarwoto, Watonah. Keperawatan medikal bedah: gangguan sistem

hematologi. Jakarta : Trans Info Media; 2008: 9-29.

27. Gandasoebrata R. Penuntun laboratorium klinik. Jakarta : Dian Rakyat; 2007:

11-14.

28. Sutedjo AY. Buku saku mengenal penyakit melalui hasil pemeriksaan

laboratorium. Yogyakarta : Penerbit Amara Books; 2009: 17-35.

29. EffendiZ. Peranan leukosit sebagai anti inflamasi alergik dalam

tubuh[internet]. 2003[cited 2015 Jan 31]. Availabel from:

library.usu.ac.id/download/fk/histologi-zukesti2.pdf.

30. Mudita IB. Sel darah putih: gangguan fungsi granulosit dan granulopoiesis. In

: Permono HB, Sutaryo, Ugrasena IGD, Windiastuti E, Abdulsalam M. Buku

ajar hematologi-onkologi anak. Jakarta : Badan Penerbit IDAI, 2012: 101-

132.

31. Kee JL. Laboratory and diagnostic tests with nursing implication. In :

Kurnianingsih S, Widyastuti P, Cahyaningrum R, Rahayu S. Pedoman

69

pemeriksaan laboratorium dan diagnostik. 6th

ed. Jakarta: Penerbit Buku

Kedokteran EGC; 2003: 479-482.

32. Onisai M, Vladareanu A, Bumbea H, Ciorascu M, Pop C, Andrei C, et al. A

study of hematologycal picture and of platelet function in preeclampsia.

Maedica : A Journal of Clinical Medicine. 2009; 4(4): 327-337.

33. Sabatier F, Bretelle F, d’Ercole C, Boubli L, Sampol J, Dignat-George F.

Neutrophil activation in preeclampsia and isolated intrauterine growth

restriction. American Journals of Obstetric and Gynecology. 2000; 183(6) :

1558-1563.

34. Mihu D, Sabau L, Costin N, Ciortea R, Oancea M, Malutan A. Evaluation of

leukocytes and neutrophils, markers of inflammatory syndrome in

preeclampsia. Applied Medical Informatics. 2010; 27(3) : 15-22.

35. Raras AA. Pengaruh preeklampsia berat pada kehamilan terhadap keluaran

maternal dan perinatal di RSUP Dr. Kariadi tahun 2010. Semarang : Fakultas

Kedokteran Universitas Diponegoro; 2011.

36. Konimusliha P. Hubungan antara frekuensi pelayanan antenatal dengan

kejadian preeklampsia berat : studi kasus di RSUP Dr. Kariadi tahun 2010.

Semarang : Fakultas Kedokteran Universitas Diponegoro; 2011.

37. Kuriakose P. Anemia: an approach to evaluation, 2014. CHRISMED Journal

of Health and Research [internet]. 2015; 2(2) : 95-99 [cited 17 Jun 2015].

Availabel from : http://www.cjhr.org/article.asp?issn=2348-

3334;year=2015;volume=2;issue=2;spage=95;epage=99;aulast=Kuriakose

70

38. Monteiro G, Subbalakshmi, Pai SR. Revelance of measurement of

hematological parameters in subjects with pregnancy induced hypertention.

Nitte University Journal of Health Science. 2014; 4(1) : 15-20.

39. Yang SW, Cho SH, Kwon HS, Sohn IS, Hwang HS. Significance of the

platelet distribution width as a severity marker for the development of

preeclampsia. European Journal of Obstetrics & Gynecology and

Reproductive Biology. 2014; 175 : 107-111.

40. Selamat, Aditiawarman. Clinical and laboratory profiles relationships of

preeclampsia-eclampsia patients with maternal mortality in Dr. Soetomo

hospital, Surabaya. Majalah Obstetri & Ginekologi. 2012; 20 (1) : 35-39.

41. Jwa SC, Fujiwara T, Yamanobe Y, Kozuka K, Sago H.Changes in maternal

hemoglobin during pregnancy and birth outcomes. BMC Pregnancy and

Childbirth. 2015; 15 : 80.

71

Lampiran 1. Ethical Clearance

72

Lampiran 2. SuratIjinPenelitian

73

Lampiran 3. Hasil Output SPSS

Deskripsi Usia Pasien Preeklampsia

Statistic Std. Error

Usia

Mean 29,05 ,770

95% Confidence Interval for

Mean

Lower Bound 27,52

Upper Bound 30,58

5% Trimmed Mean 28,91

Median 28,00

Variance 50,379

Std. Deviation 7,098

Minimum 16

Maximum 48

Range 32

Interquartile Range 12

Skewness ,253 ,261

Kurtosis -,718 ,517

Deskripsi Usia Kelompok Kontrol


Usia

Mean 27,88 ,658


Mean

Lower Bound 26,57

Upper Bound 29,19


Median 28,00

Variance 36,819


Minimum 15

Maximum 47

Range 32


Skewness ,251 ,261

Kurtosis ,110 ,517

74

Frekuensi Usia Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent

Valid

<20 tahun 1 7,7 7,7 7,7

20-35 tahun 9 69,2 69,2 76,9

>35 tahun 3 23,1 23,1 100,0

Total 13 100,0 100,0

Frekuensi Usia Preeklampsia Berat


Valid

<20 tahun 4 7,1 7,1 7,1

20-35 tahun 37 66,1 66,1 73,2

>35 tahun 15 26,8 26,8 100,0

Total 56 100,0 100,0

Frekuensi Usia Eklampsia


Valid

<20 tahun 2 12,5 12,5 12,5

20-35 tahun 12 75,0 75,0 87,5

>35 tahun 2 12,5 12,5 100,0

Total 16 100,0 100,0

Frekuensi Usia Kelompok Kontrol

Frequency Percent Valid Percent Cumulative

Percent

Valid

<20 tahun 9 10,6 10,6 10,6

20-35 tahun 10 11,8 11,8 22,4

>35 tahun 66 77,6 77,6 100,0

Total 85 100,0 100,0

Frekuensi Alamat Preeklampsia Ringan


Percent

Valid

Semarang 12 92,3 92,3 92,3

Luar Semarang 1 7,7 7,7 100,0

Total 13 100,0 100,0

Frekuensi Alamat Preeklampsia Berat


Percent

Valid

Semarang 33 58,9 58,9 58,9

Luar Semarang 23 41,1 41,1 100,0

Total 56 100,0 100,0

75

Frekuensi Alamat Eklampsia


Percent

Valid

Semarang 4 25,0 25,0 25,0

Luar Semarang 12 75,0 75,0 100,0

Total 16 100,0 100,0

Frekuensi Alamat Kelompok Kontrol


Percent

Valid

Semarang 68 80,0 80,0 80,0

Luar Semarang 17 20,0 20,0 100,0

Total 85 100,0 100,0

Frekuensi Tingkat Pendidikan Preeklampsia Ringan


Percent

Valid

Dasar 4 30,8 30,8 30,8

Menengah 9 69,2 69,2 100,0

Total 13 100,0 100,0

FrekuensiTingkat Pendidikan Preeklampsia Berat


Percent

Valid

Tidak Sekolah 3 5,4 5,4 5,4

Dasar 22 39,3 39,3 44,6

Menengah 26 46,4 46,4 91,1

Tinggi 5 8,9 8,9 100,0

Total 56 100,0 100,0

FrekuensiTingkat Pendidikan Eklampsia


Percent

Valid

Tidak Sekolah 2 12,5 12,5 12,5

Dasar 5 31,3 31,3 43,8

Menengah 9 56,3 56,3 100,0

Total 16 100,0 100,0

76

FrekuensiTingkat Pendidikan Kelompok Kontrol


Percent

Valid

Dasar 17 20,0 20,0 20,0

Menengah 43 50,6 50,6 70,6

Tinggi 25 29,4 29,4 100,0

Total 85 100,0 100,0

FrekuensiStatus Pekerjaan Preeklampsia Ringan


Percent

Valid

Bekerja 1 7,7 7,7 7,7

Tidak Bekerja 12 92,3 92,3 100,0

Total 13 100,0 100,0

FrekuensiStatus Pekerjaan Preeklampsia Berat


Percent

Valid

Bekerja 13 23,2 23,2 23,2

Tidak Bekerja 43 76,8 76,8 100,0

Total 56 100,0 100,0

FrekuensiStatus Pekerjaan Eklampsia


Percent

Valid

Bekerja 2 12,5 12,5 12,5

Tidak Bekerja 14 87,5 87,5 100,0

Total 16 100,0 100,0

FrekuensiStatus Pekerjaan Kelompok Kontrol


Percent

Valid

Bekerja 23 27,1 27,1 27,1

Tidak Bekerja 62 72,9 72,9 100,0

Total 85 100,0 100,0

FrekuensiGravida Preeklampsia Ringan


Percent

Valid

Primigravida 6 46,2 46,2 46,2

Multigravida 7 53,8 53,8 100,0

Total 13 100,0 100,0

77

FrekuensiGravida Preeklampsia Berat


Percent

Valid



Grande Multigravida 3 5,4 5,4 100,0

Total 56 100,0 100,0

FrekuensiGravida Eklampsia


Percent

Valid




Total 16 100,0 100,0

FrekuensiGravida Kelompok Kontrol


Percent

Valid




Total 85 100,0 100,0

Frekuensi Jumlah Paritas Preeklampsia Ringan


Percent

Valid

Nulipara 7 53,8 53,8 53,8

Primipara 2 15,4 15,4 69,2

Multipara 4 30,8 30,8 100,0

Total 13 100,0 100,0

Frekuensi Jumlah ParitasPreeklampsia Berat


Percent

Valid

Nulipara 15 26,8 26,8 26,8

Primipara 19 33,9 33,9 60,7

Multipara 22 39,3 39,3 100,0

Total 56 100,0 100,0

78

Frekuensi Jumlah Paritas Eklampsia


Percent

Valid

Nullipara 12 75,0 75,0 75,0

Primipara 1 6,3 6,3 81,3

Multipara 3 18,8 18,8 100,0

Total 16 100,0 100,0

Frekuensi Jumlah Paritas Kelompok Kontrol


Percent

Valid

Nullipara 34 40,0 40,0 40,0

Primipara 28 32,9 32,9 72,9

Multipara 21 24,7 24,7 97,6

Grande Multipara 2 2,4 2,4 100,0

Total 85 100,0 100,0

Deskripsi Usia Kehamilan Preeklampsia


Usia Kehamilan

Mean 36,25 ,338


Mean

Lower Bound 35,57

Upper Bound 36,92


Median 37,00

Variance 9,712


Minimum 28

Maximum 42

Range 14


Skewness -,702 ,261

Kurtosis -,117 ,517

79

Deskripsi Usia Kehamilan Kelompok Kontrol


Usia Kehamilan

Mean 38,27 ,259


Mean

Lower Bound 37,76

Upper Bound 38,79


Median 39,00

Variance 5,700


Minimum 27

Maximum 42

Range 15


Skewness -1,931 ,261

Kurtosis 5,917 ,517

Frekuensi Usia Kehamilan Preeklampsia Ringan


Percent

Valid

Prematur 2 15,4 15,4 15,4

Aterm 11 84,6 84,6 100,0

Total 13 100,0 100,0

FrekuensiUsia Kehamilan Preeklampsia Berat


Percent

Valid

Prematur 24 42,9 42,9 42,9

Aterm 30 53,6 53,6 96,4

Serotinus 2 3,6 3,6 100,0

Total 56 100,0 100,0

FrekuensiUsia Kehamilan Eklampsia


Percent

Valid

Prematur 9 56,3 56,3 56,3

Aterm 6 37,5 37,5 93,8

Serotinus 1 6,3 6,3 100,0

Total 16 100,0 100,0

80

FrekuensiUsia Kehamilan Kelompok Kontrol


Percent

Valid

Prematur 10 11,8 11,8 11,8

Aterm 65 76,5 76,5 88,2

Serotinus 10 11,8 11,8 100,0

Total 85 100,0 100,0

Frekuensi ANC Preeklampsia Ringan


Percent

Valid

<4 3 23,1 23,1 23,1

≥4 10 76,9 76,9 100,0

Total 13 100,0 100,0

FrekuensiANC Preeklampsia Berat


Percent

Valid

<4 9 16,1 16,1 16,1

≥4 47 83,9 83,9 100,0

Total 56 100,0 100,0

Frekuensi ANC Eklampsia


Percent

Valid

<4 4 25,0 25,0 25,0

≥4 12 75,0 75,0 100,0

Total 16 100,0 100,0

Frekuensi ANC Kelompok Kontrol


Percent

Valid

<4 13 15,3 15,3 15,3

≥4 72 84,7 84,7 100,0

Total 85 100,0 100,0

FrekuensiRujukan Preeklampsia Ringan


Percent

Valid

Datang Sendiri 8 61,5 61,5 61,5

Bidan 2 15,4 15,4 76,9

Dokter Umum 1 7,7 7,7 84,6

RS Pemerintah 1 7,7 7,7 92,3

RS Swasta 1 7,7 7,7 100,0

Total 13 100,0 100,0

81

FrekuensiRujukan Preeklampsia Berat


Percent

Valid


Bidan 8 14,3 14,3 69,6

Dokter Umum 3 5,4 5,4 75,0


RS Swasta 5 8,9 8,9 100,0

Total 56 100,0 100,0

FrekuensiRujukan Eklampsia


Percent

Valid



RS Swasta 2 12,5 12,5 100,0

Total 16 100,0 100,0

Frekuensi Rujukan Kelompok Kontrol


Percent

Valid


Bidan 8 9,4 9,4 85,9

Dokter Umum 3 3,5 3,5 89,4

Dokter Spesialis 2 2,4 2,4 91,8


Puskesmas 2 2,4 2,4 98,8

BP/Poliklinik 1 1,2 1,2 100,0

Total 85 100,0 100,0

FrekuensiJenis Partus Preeklampsia Ringan


Percent

Valid

Bedah Sesar 2 15,4 15,4 15,4

Spontan Pervaginam 7 53,8 53,8 69,2

Vakum Pervaginam 4 30,8 30,8 100,0

Total 13 100,0 100,0

82

FrekuensiJenis Partus Preeklampsia Berat


Percent

Valid

Bedah Sesar 27 48,2 48,2 48,2


Vakum Pervaginam 6 10,7 10,7 100,0

Total 56 100,0 100,0

FrekuensiJenis Partus Eklampsia


Percent

Valid

Bedah Sesar 13 81,3 81,3 81,3


Total 16 100,0 100,0

FrekuensiJenis Partus Kelompok Kontrol


Percent

Valid Spontan Pervaginam 85 100,0 100,0 100,0

Frekuensi BMI Preeklampsia Ringan


Percent

Valid

≥25 1 7,7 7,7 7,7

<25 12 92,3 92,3 100,0

Total 13 100,0 100,0

Frekuensi BMI Preeklampsia Berat


Percent

Valid

≥25 20 35,7 35,7 35,7

<25 36 64,3 64,3 100,0

Total 56 100,0 100,0

Frekuensi BMI Eklampsia


Percent

Valid <25 16 100,0 100,0 100,0

83

Frekuensi BMI Kelompok Kontrol


Percent

Valid

≥25 2 2,4 2,4 2,4

<25 83 97,6 97,6 100,0

Total 85 100,0 100,0

Frekuensi Anemia Preeklampsia Ringan


Percent

Valid

Anemia Mikrositik

Hipokromik

2 15,4 15,4 15,4

Anemia Normositik

Normokromik

1 7,7 7,7 23,1

Tidak Anemia 10 76,9 76,9 100,0

Total 13 100,0 100,0

Frekuensi Anemia Preeklampsia Berat


Percent

Valid

Anemia Mikrositik

Hipokromik

3 5,4 5,4 5,4

Tidak Anemia 53 94,6 94,6 100,0

Total 56 100,0 100,0

Anemia


Percent

Valid

Anemia Mikrositik

Hipokromik

1 6,3 6,3 6,3

Tidak Anemia 15 93,8 93,8 100,0

Total 16 100,0 100,0

Frekuensi Anemia Kelompok Kontrol


Percent

Valid

Anemia Mikrositik

Hipokromik

9 10,6 10,6 10,6

Anemia Normositik

Normokromik

1 1,2 1,2 11,8

Tidak Anemia 75 88,2 88,2 100,0

Total 85 100,0 100,0

84

Frekuensi Sindroma HELLP Preeklampsi Ringan


Percent

Valid Tidak Sindroma HELLP 13 100,0 100,0 100,0

Frekuensi Sindroma HELLP Preeklampsia Berat


Percent

Valid

Sindroma HELLP 6 10,7 10,7 10,7

Tidak Sindroma HELLP 50 89,3 89,3 100,0

Total 56 100,0 100,0

Frekuensi Sindroma HELLP Eklampsia


Percent

Valid

Sindroma HELLP 1 6,3 6,3 6,3

Tidak Sindroma HELLP 15 93,8 93,8 100,0

Total 16 100,0 100,0

Frekuensi Sindroma HELLP Kelompok Kontrol


Percent

Valid Tidak Sindroma HELLP 85 100,0 100,0 100,0

Kejang pada Eklampsia


Percent

Valid Kejang 16 100,0 100,0 100,0

Deskripsi Profil Hematologi

Jenis_perlakuan Statistic Std. Error

Eritrosit Eklampsia

Mean 4,3563 ,19205


Mean

Lower Bound 3,9469

Upper Bound 4,7656


Median 4,4500

Variance ,590

Std. Deviation ,76821

Minimum 2,20

Maximum 5,62

Range 3,42

Interquartile Range ,61


Kurtosis 3,644 1,091

85

Eritrosit

PE Berat

Mean 4,4535 ,06709

95% Confidence Interval for Mean

Lower Bound 4,3191

Upper Bound 4,5880


Median 4,5000

Variance ,252


Minimum 3,30

Maximum 5,60

Range 2,30

Interquartile Range ,54 Skewness ,295 ,319

Kurtosis ,147 ,628

PE Ringan

Mean 3,8655 ,14695


Lower Bound 3,5453

Upper Bound 4,1856


Median 3,8000

Variance ,281


Minimum 2,60

Maximum 4,80

Range 2,20

Interquartile Range ,50 Skewness -,713 ,616


Kontrol

Mean 4,0863 ,04989


Lower Bound 3,9871

Upper Bound 4,1855


Median 4,1000

Variance ,212


Minimum 2,10

Maximum 5,20

Range 3,10

Interquartile Range ,55 Skewness -,639 ,261

Kurtosis 3,286 ,517

86

Hemoglobin

Eklampsia

Mean 12,3500 ,49007


Mean

Lower Bound 11,3054

Upper Bound 13,3946


Median 12,8500

Variance 3,843


Minimum 6,30

Maximum 14,30

Range 8,00

Interquartile Range 1,58 Skewness -2,250 ,564


PE Berat

Mean 12,4609 ,22712


Mean

Lower Bound 12,0057

Upper Bound 12,9161


Median 12,6500

Variance 2,889


Minimum 8,50

Maximum 16,90

Range 8,40

Interquartile Range 1,95 Skewness ,023 ,319

Kurtosis ,327 ,628

PE Ringan

Mean 10,8062 ,47592


Mean

Lower Bound 9,7692

Upper Bound 11,8431


Median 10,8000

Variance 2,944


Minimum 7,80

Maximum 13,60

Range 5,80


Kurtosis -,666 1,191

87

Kontrol

Mean 11,5136 ,17949


Mean

Lower Bound 11,1567

Upper Bound 11,8706


Median 11,7200

Variance 2,738


Minimum 7,10

Maximum 14,60

Range 7,50

Interquartile Range 2,00

Skewness -,766 ,261

Kurtosis ,320 ,517

Hematokrit

Eklampsia

Mean 36,2188 1,41728


Mean

Lower Bound 33,1979

Upper Bound 39,2396


Median 38,5500

Variance 32,139


Minimum 18,60

Maximum 41,30

Range 22,70



PE Berat

Mean 36,5673 ,61608


Mean

Lower Bound 35,3327

Upper Bound 37,8020


Median 36,9350

Variance 21,255


Minimum 25,90

Maximum 48,00

Range 22,10


Kurtosis ,408 ,628

Hemoglobin

88

Hematokrit

PE Ringan

Mean 31,9623 1,24425


Mean

Lower Bound 29,2513

Upper Bound 34,6733


Median 33,4000

Variance 20,126


Minimum 23,80

Maximum 38,30

Range 14,50


Skewness -,326 ,616


Kontrol

Mean 33,5013 ,48095


Mean

Lower Bound 32,5449

Upper Bound 34,4577


Median 34,2000

Variance 19,662


Minimum 22,10

Maximum 42,80

Range 20,70

Interquartile Range 6,05 Skewness -,604 ,261

Kurtosis ,190 ,517

MCH Eklampsia

Mean 28,1125 ,74184


Mean

Lower Bound 26,5313

Upper Bound 29,6937


Median 28,7000

Variance 8,805


Minimum 23,00

Maximum 33,50

Range 10,50



89

PE Berat

Mean 28,1013 ,38351


Mean

Lower Bound 27,3327

Upper Bound 28,8698


Median 28,7000

Variance 8,236


Minimum 18,80

Maximum 32,68

Range 13,88



Kurtosis 1,858 ,628

PE Ringan

Mean 28,2331 ,78008


Mean

Lower Bound 26,5334

Upper Bound 29,9327


Median 28,5000

Variance 7,911


Minimum 22,40

Maximum 31,90

Range 9,50


Kurtosis ,114 1,191

Kontrol

Mean 28,2878 ,41249


Mean

Lower Bound 27,4675

Upper Bound 29,1080


Median 29,0000

Variance 14,462


Minimum 18,70

Maximum 40,90

Range 22,20


Kurtosis 1,174 ,517

MCH

90

MCV

Eklampsia

Mean 82,9125 1,74052


Mean

Lower Bound 79,2027

Upper Bound 86,6223


Median 83,6500

Variance 48,471


Minimum 68,80

Maximum 91,90

Range 23,10


Kurtosis ,014 1,091

PE Berat

Mean 82,2202 ,91094


Mean

Lower Bound 80,3946

Upper Bound 84,0457


Median 83,2500

Variance 46,470


Minimum 58,80

Maximum 93,20

Range 34,40


Kurtosis 2,829 ,628

PE Ringan

Mean 83,7623 2,36788


Mean

Lower Bound 78,6031

Upper Bound 88,9215


Median 88,5000

Variance 72,889


Minimum 67,60

Maximum 94,00

Range 26,40



91

MCV Kontrol

Mean 82,2678 1,04077


Mean

Lower Bound 80,1981

Upper Bound 84,3375


Median 84,3000

Variance 92,072


Minimum 58,70

Maximum 118,20

Range 59,50


Skewness -,217 ,261

Kurtosis 1,981 ,517

MCHC

Eklampsia

Mean 33,8563 ,37081


Mean

Lower Bound 33,0659

Upper Bound 34,6466


Median 33,7000

Variance 2,200


Minimum 30,60

Maximum 36,50

Range 5,90


Kurtosis ,974 1,091

PE Berat

Mean 34,0146 ,18532


Mean

Lower Bound 33,6433

Upper Bound 34,3860


Median 34,1000

Variance 1,923


Minimum 30,30

Maximum 36,50

Range 6,20


Kurtosis -,334 ,628

92

PE Ringan

Mean 33,7600 ,43200


Mean

Lower Bound 32,8187

Upper Bound 34,7013


Median 33,9000

Variance 2,426


Minimum 29,70

Maximum 35,60

Range 5,90




Kontrol

Mean 34,3093 ,12284


Mean

Lower Bound 34,0650

Upper Bound 34,5536


Median 34,3000

Variance 1,283


Minimum 31,30

Maximum 36,60

Range 5,30


Kurtosis -,078 ,517

Leukosit

Eklampsia

Mean 20,3756 1,81807


Mean

Lower Bound 16,5005

Upper Bound 24,2507


Median 20,0500

Variance 52,886


Minimum 10,20

Maximum 31,80

Range 21,60


Kurtosis -1,272 1,091

MCHC

93

PE Berat

Mean 14,5888 ,50729


Mean

Lower Bound 13,5721

Upper Bound 15,6054


Median 13,4500

Variance 14,411


Minimum 6,23

Maximum 25,90

Range 19,67


Kurtosis ,394 ,628

PE Ringan

Mean 13,4500 1,03077


Mean

Lower Bound 11,2042

Upper Bound 15,6958


Median 13,4000

Variance 13,812


Minimum 8,84

Maximum 20,71

Range 11,87


Kurtosis ,200 1,191

Kontrol

Mean 12,4215 ,34491


Mean

Lower Bound 11,7356

Upper Bound 13,1074


Median 12,3000

Variance 10,112


Minimum 6,60

Maximum 23,20

Range 16,60


Kurtosis ,403 ,517

Leukosit

94

Trombosit

Eklampsia

Mean 247,3313 26,89517


Mean

Lower Bound 190,0056

Upper Bound 304,6569


Median 256,5000

Variance 11573,602


Minimum 51,40

Maximum 420,00

Range 368,60


Skewness -,246 ,564


PE Berat

Mean 223,7782 12,58424





Median 246,9500

Variance 8868,336


Minimum 8,90

Maximum 387,80

Range 378,90


Kurtosis -,354 ,628

PE Ringan

Mean 248,5615 19,39924





Median 233,1000

Variance 4892,294


Minimum 148,00

Maximum 373,00

Range 225,00



95

Kontrol

Mean 254,1165 6,72605


Mean




Median 250,0000

Variance 3845,380


Minimum 133,30

Maximum 458,80

Range 325,50


Skewness ,596 ,261

Kurtosis ,341 ,517

Tes Normalitas Data

Kolmogorov-Smirnova Shapiro-Wilk

Statistic df Sig. Statistic df Sig.

Eritrosit ,076 170 ,018 ,962 170 ,000

Hemoglobin ,084 170 ,005 ,975 170 ,004

Hematokrit ,081 170 ,008 ,977 170 ,007

MCH ,117 170 ,000 ,943 170 ,000

MCV ,139 170 ,000 ,922 170 ,000

MCHC ,077 170 ,015 ,978 170 ,008

Leukosit ,129 170 ,000 ,909 170 ,000

Trombosit ,054 170 ,200* ,987 170 ,123

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction

Tes Normalitas Transformasi Data



Hemoglobin ,116 170 ,000 ,934 170 ,000

Hematokrit ,113 170 ,000 ,942 170 ,000

MCH ,141 170 ,000 ,912 170 ,000

MCV ,160 170 ,000 ,900 170 ,000

Leukosit ,066 170 ,064 ,988 170 ,147


Trombosit

96

Tes Homogenitas Varian Data

Levene Statistic df1 df2 Sig.

Eritrosit ,899 3 166 ,443

Hemoglobin ,018 3 166 ,997

Hematokrit ,086 3 166 ,968

MCH 1,543 3 166 ,205

MCV 2,205 3 166 ,089

MCHC 1,140 3 166 ,334

Leukosit 9,779 3 166 ,000

Trombosit 5,316 3 166 ,002

Tes Homogenitas Varian Transformasi Data

Levene Statistic df1 df2 Sig.

Leukosit ,952 3 166 ,417

Trombosit 7,894 3 166 ,000

Uji One Way ANOVA

Sum of Squares Df Mean Square F Sig.

Eritrosit

Between Groups 6,501 3 2,167 8,201 ,000

Within Groups 43,860 166 ,264

Total 50,361 169

MCHC

Between Groups 6,455 3 2,152 1,296 ,278

Within Groups 275,634 166 1,660

Total 282,089 169

Leukosit

Between Groups 885,268 3 295,089 18,833 ,000

Within Groups 2601,045 166 15,669

Total 3486,313 169

97

Kruskal-Wallis Test

Ranks

Jenis_perlakuan N Mean Rank

Hemoglobin

Eklampsia 16 108,84

PE Berat 56 100,96

PE Ringan 13 55,96

Kontrol 85 75,44

Total 170

Hematokrit

Eklampsia 16 113,63

PE Berat 56 103,24

PE Ringan 13 57,54

Kontrol 85 72,79

Total 170

MCH

Eklampsia 16 80,09

PE Berat 56 82,76

PE Ringan 13 83,85

Kontrol 85 88,58

Total 170

MCV

Eklampsia 16 88,28

PE Berat 56 81,28

PE Ringan 13 96,54

Kontrol 85 86,07

Total 170

Trombosit

Eklampsia 16 90,16

PE Berat 56 76,98

PE Ringan 13 85,00

Kontrol 85 90,31

Total 170

Test Statisticsa,b

Hemoglobin Hematokrit MCH MCV Trombosit

Chi-Square 17,362 22,365 ,714 1,129 2,634

df 3 3 3 3 3

Asymp. Sig. ,001 ,000 ,870 ,770 ,452

a. Kruskal Wallis Test

b. Grouping Variable: Jenis_perlakuan

98

Post Hoc Tests

Multiple Comparisons

LSD

Dependent

Variable

(I)

Jenis_perlak

uan

(J)

Jenis_perla

kuan

Mean Difference

(I-J)

Std. Error Sig. 95% Confidence Interval

Lower Bound Upper Bound

Eritrosit

Eklampsia

PE Berat -,09727 ,14571 ,505 -,3850 ,1904

PE Ringan ,49079* ,19193 ,011 ,1118 ,8697

Kontrol ,26993 ,14008 ,056 -,0066 ,5465

PE Berat

Eklampsia ,09727 ,14571 ,505 -,1904 ,3850

PE Ringan ,58806* ,15825 ,000 ,2756 ,9005

Kontrol ,36720* ,08847 ,000 ,1925 ,5419

PE Ringan

Eklampsia -,49079* ,19193 ,011 -,8697 -,1118

PE Berat -,58806* ,15825 ,000 -,9005 -,2756

Kontrol -,22086 ,15308 ,151 -,5231 ,0814

Kontrol

Eklampsia -,26993 ,14008 ,056 -,5465 ,0066

PE Berat -,36720* ,08847 ,000 -,5419 -,1925

PE Ringan ,22086 ,15308 ,151 -,0814 ,5231

Hemoglobin

Eklampsia

PE Berat -,11089 ,48298 ,819 -1,0645 ,8427

PE Ringan 1,54385* ,63618 ,016 ,2878 2,7999

Kontrol ,83635 ,46431 ,073 -,0804 1,7531

PE Berat

Eklampsia ,11089 ,48298 ,819 -,8427 1,0645

PE Ringan 1,65474* ,52453 ,002 ,6191 2,6904

Kontrol ,94725* ,29324 ,001 ,3683 1,5262

PE Ringan

Eklampsia -1,54385* ,63618 ,016 -2,7999 -,2878

PE Berat -1,65474* ,52453 ,002 -2,6904 -,6191

Kontrol -,70749 ,50740 ,165 -1,7093 ,2943

Kontrol

Eklampsia -,83635 ,46431 ,073 -1,7531 ,0804

PE Berat -,94725* ,29324 ,001 -1,5262 -,3683

PE Ringan ,70749 ,50740 ,165 -,2943 1,7093

99

Hematokrit

Eklampsia

PE Berat -,34857 1,30984 ,790 -2,9347 2,2375

PE Ringan 4,25644* 1,72534 ,015 ,8500 7,6629

Kontrol 2,71746* 1,25921 ,032 ,2313 5,2036

PE Berat Eklampsia ,34857 1,30984 ,790 -2,2375 2,9347

PE Ringan 4,60501

* 1,42254 ,001 1,7964 7,4136

Kontrol 3,06603* ,79527 ,000 1,4959 4,6362

PE Ringan

Eklampsia -4,25644* 1,72534 ,015 -7,6629 -,8500

PE Berat -4,60501* 1,42254 ,001 -7,4136 -1,7964

Kontrol -1,53899 1,37606 ,265 -4,2558 1,1779

Kontrol

Eklampsia -2,71746* 1,25921 ,032 -5,2036 -,2313

PE Berat -3,06603* ,79527 ,000 -4,6362 -1,4959

PE Ringan 1,53899 1,37606 ,265 -1,1779 4,2558

MCH

Eklampsia

PE Berat ,01125 ,95774 ,991 -1,8797 1,9022

PE Ringan -,12058 1,26154 ,924 -2,6113 2,3702

Kontrol -,17526 ,92071 ,849 -1,9931 1,6426

PE Berat

Eklampsia -,01125 ,95774 ,991 -1,9022 1,8797

PE Ringan -,13183 1,04014 ,899 -2,1854 1,9218

Kontrol -,18651 ,58149 ,749 -1,3346 ,9615

PE Ringan

Eklampsia ,12058 1,26154 ,924 -2,3702 2,6113

PE Berat ,13183 1,04014 ,899 -1,9218 2,1854

Kontrol -,05469 1,00616 ,957 -2,0412 1,9318

Kontrol

Eklampsia ,17526 ,92071 ,849 -1,6426 1,9931

PE Berat ,18651 ,58149 ,749 -,9615 1,3346

PE Ringan ,05469 1,00616 ,957 -1,9318 2,0412

MCV

Eklampsia

PE Berat ,69232 2,39927 ,773 -4,0447 5,4293

PE Ringan -,84981 3,16034 ,788 -7,0895 5,3898

Kontrol ,64474 2,30652 ,780 -3,9092 5,1986

PE Berat

Eklampsia -,69232 2,39927 ,773 -5,4293 4,0447

PE Ringan -1,54213 2,60571 ,555 -6,6867 3,6025

Kontrol -,04759 1,45671 ,974 -2,9237 2,8285

PE Ringan

Eklampsia ,84981 3,16034 ,788 -5,3898 7,0895

PE Berat 1,54213 2,60571 ,555 -3,6025 6,6867

Kontrol 1,49454 2,52057 ,554 -3,4820 6,4710

100

Kontrol

Eklampsia -,64474 2,30652 ,780 -5,1986 3,9092

PE Berat ,04759 1,45671 ,974 -2,8285 2,9237

PE Ringan -1,49454 2,52057 ,554 -6,4710 3,4820

MCHC Eklampsia

PE Berat -,15839 ,36528 ,665 -,8796 ,5628

PE Ringan ,09625 ,48115 ,842 -,8537 1,0462

Kontrol -,45304 ,35116 ,199 -1,1464 ,2403

PE Berat

Eklampsia ,15839 ,36528 ,665 -,5628 ,8796

PE Ringan ,25464 ,39671 ,522 -,5286 1,0379

Kontrol -,29465 ,22178 ,186 -,7325 ,1432

PE Ringan

Eklampsia -,09625 ,48115 ,842 -1,0462 ,8537

PE Berat -,25464 ,39671 ,522 -1,0379 ,5286

Kontrol -,54929 ,38375 ,154 -1,3069 ,2084

Kontrol

Eklampsia ,45304 ,35116 ,199 -,2403 1,1464

PE Berat ,29465 ,22178 ,186 -,1432 ,7325

PE Ringan ,54929 ,38375 ,154 -,2084 1,3069

Leukosit

Eklampsia

PE Berat 5,78688* 1,12210 ,000 3,5714 8,0023

PE Ringan 6,92563* 1,47804 ,000 4,0074 9,8438

Kontrol 7,95410* 1,07873 ,000 5,8243 10,0839

PE Berat

Eklampsia -5,78688* 1,12210 ,000 -8,0023 -3,5714

PE Ringan 1,13875 1,21865 ,351 -1,2673 3,5448

Kontrol 2,16722* ,68128 ,002 ,8221 3,5123

PE Ringan

Eklampsia -6,92563* 1,47804 ,000 -9,8438 -4,0074

PE Berat -1,13875 1,21865 ,351 -3,5448 1,2673

Kontrol 1,02847 1,17883 ,384 -1,2990 3,3559

Kontrol

Eklampsia -7,95410* 1,07873 ,000 -10,0839 -5,8243

PE Berat -2,16722* ,68128 ,002 -3,5123 -,8221

PE Ringan -1,02847 1,17883 ,384 -3,3559 1,2990

Trombosit

Eklampsia

PE Berat 23,55304 22,47074 ,296 -20,8122 67,9183

PE Ringan -1,23029 29,59869 ,967 -59,6687 57,2081

Kontrol -6,78522 21,60212 ,754 -49,4355 35,8651

PE Berat Eklampsia -23,55304 22,47074 ,296 -67,9183 20,8122

PE Ringan -24,78332 24,40417 ,311 -72,9659 23,3992

101

Kontrol -30,33826* 13,64304 ,028 -57,2745 -3,4020

PE Ringan

Eklampsia 1,23029 29,59869 ,967 -57,2081 59,6687

PE Berat 24,78332 24,40417 ,311 -23,3992 72,9659

Kontrol -5,55493 23,60680 ,814 -52,1632 41,0533

Kontrol

Eklampsia 6,78522 21,60212 ,754 -35,8651 49,4355

PE Berat 30,33826* 13,64304 ,028 3,4020 57,2745

PE Ringan 5,55493 23,60680 ,814 -41,0533 52,1632

*. The mean difference is significant at the 0.05 level.

Deskripsi Hemogbin dan Berat Bayi Lahir


Hemoglobin

Mean 1,0684 ,00536


Mean

Lower Bound 1,0578

Upper Bound 1,0790


Median 1,0810

Variance ,005


Minimum ,80

Maximum 1,23

Range ,43



Kurtosis 1,656 ,370

BBL

Mean 3,4224 ,01175


Mean

Lower Bound 3,3992

Upper Bound 3,4456


Median 3,4624

102

Variance ,023


Minimum 2,54

Maximum 3,66

Range 1,12



Kurtosis 8,192 ,370

Tes Normalitas Hemogbin dan Berat Bayi Lahir


Statistic Df Sig. Statistic df Sig.

Hemoglobin ,084 170 ,005 ,975 170 ,004

BBL ,118 170 ,000 ,961 170 ,000


Tes Normalitas Transformasi Hemogbin dan Berat Bayi Lahir



Hemoglobin ,116 170 ,000 ,934 170 ,000

BBL ,170 170 ,000 ,799 170 ,000


Uji Korelas Spearman

Hemoglobin BBL

Hemoglobin

Pearson Correlation 1 -,269**

Sig. (2-tailed) ,000

N 170 170

BBL

Pearson Correlation -,269** 1

Sig. (2-tailed) ,000

N 170 170

**. Correlation is significant at the 0.01 level (2-tailed

103

Lampiran 4. Biodata Mahasiswa

Identitas

Nama : Candra Cahyaningtyas Giyanto

NIM : 22010111130090

Tempat/ tanggal lahir : Pekalongan, 28 Agustus 1993

Jenis kelamin : Perempuan

Alamat : JalanLPPU II No. 11 Tembalang, RT 02/RW 04,

Semarang

Nomor HP : 085866239993

E-mail : [email protected]

Riwayat Pendidikan Formal

1. SD : SD Negeri Doro 01 Lulus tahun : 2005

2. SMP : SMP Negeri 2 Pekalongan Lulus tahun : 2008

3. SMA : SMA Negeri 1 Pekalongan Lulus tahun : 2011

4. FK UNDIP : Masuk tahun : 2011

Keanggotaan Organisasi

1. Anggota RHEU tahun 2014

2. Asisten Parasitologi tahun 2014

Pengalaman Penelitian -

Pengalaman Publikasi Tulisan Ilmiah -

Pengalaman Presentasi Karya Tulis -

Pengalaman Mengikuti Lomba Karya Ilmiah -

daftar pustaka - eprints.undip.ac.ideprints.undip.ac.id/46164/9/candra_cahyaningtyas_giyanto... ·...

Documents